Comments
Loading...

Vivos Therapeutics

VVOSNASDAQ
Logo brought to you by Benzinga Data
$3.04
-0.04-1.30%
Last update: 9:27 AM
15 minutes delayed

Vivos Therapeutics (NASDAQ:VVOS) Stock, Earnings Estimates, EPS, And Revenue

Vivos Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.

Earnings Date
Nov 12
EPS Estimate
$-0.780
Quarterly Revenue Estimate
$3.9M
Annual Revenue
(as of Jun 30)
$14M

Analyze the earnings history of Vivos Therapeutics using advanced sorting and filters.

Data brought to you by Benzinga APIs

Vivos Therapeutics (VVOS) Earnings Per Share

Quarterly Earnings Surprise Amount

Fiscal Quarter EndDate ReportedActual EPSEstimated EPSSurprise %
Jun 20242024-08-14$-0.60$-1.0542.9 %
Dec 20232024-03-28$-3.05$-1.90-60.5 %
Jun 20232023-08-16$-4.50$-3.50-28.6 %
Mar 20232023-06-08$-5.00$-4.50-11.1 %

Vivos Therapeutics (VVOS) Revenue

Quarterly Revenue Surprise Amount

Fiscal Quarter EndDate ReportedActual RevenueEstimated RevenueSurprise %
Jun 20242024-08-14$4.05M$3.60M12.6 %
Dec 20232024-03-28$3.25M$3.41M-4.75 %
Jun 20232023-08-16$3.40M$4.15M-18.2 %
Mar 20232023-06-08$3.86M$4.01M-3.82 %

FAQ

Q

When is Vivos Therapeutics (NASDAQ:VVOS) reporting earnings?

A

Vivos Therapeutics (VVOS) is scheduled to report earnings on November 12, 2024. The last reported earnings were for reported on August 14, 2024 for Q2.

Q

What were the latest earnings per share (EPS) for Vivos Therapeutics (NASDAQ:VVOS)?

A

The Actual EPS was $-0.60, which beat the estimate of $-1.05.

Q

What were Vivos Therapeutics’s (NASDAQ:VVOS) revenues?

A

The Actual Revenue was $4.1M, which beat the estimate of $3.6M.

Browse earnings estimates, EPS, and revenue on all stocks.

People Also Watch